This week’s Repatriation and
General Hospital Pharmacy
E-Bulletin looks at the role of
vitamin K2 in osteoporosis.
The bulletin points out that the
evidence for vitamin K impact on
bone health is “conflicting” with a
“lack of good quality randomised
controlled trials in sufficiently large
numbers of patients”.
All vitamin K preparations also
antagonise the effects of warfarin.The above article was sent to subscribers in Pharmacy Daily's issue from 07 Dec 15 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 07 Dec 15
RESPONDING to the findings from the Royal Commission into Aged Care Quality and Safety, a recent government initiative aims to improve medication management in residential aged care facilities by introducing on-site pharmacists.
RESEARCHERS at Charles Darwin University (CDU) are advancing a novel drug delivery system that could potentially eliminate the need for injections to treat various chronic diseases.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.